Key result
JZTX-34 matches morphine for early rodent pain relief and outperforms it in later phases.
JZTX-34 exhibits potent analgesic effects by selectively binding to the domain II voltage sensor of Nav1.7 in a closed configuration.
Supports Nav1.7 blockade for analgesia; hypothesis-generating and requires human trials before clinical consideration.
Jingzhaotoxin-34 (JZTX-34) is a selective inhibitor of tetrodotoxin-sensitive (TTX-S) sodium channels. In this study, we found that JZTX-34 selectively acted on Nav1.7 with little effect on other sodium channel subtypes including Nav1.5. If the DIIS3-S4 linker of Nav1.5 is substituted by the correspond linker of Nav1.7, the sensitivity of Nav1.5 to JZTX-34 extremely increases to 1.05 µM. Meanwhile, a mutant D816R in the DIIS3-S4 linker of Nav1.7 decreases binding affinity of Nav1.7 to JZTX-34 about 32-fold. The reverse mutant R800D at the corresponding position in Nav1.5 greatly increased its binding affinity to JZTX-34. This implies that JZTX-34 binds to DIIS3-S4 linker of Nav1.7 and the critical residue of Nav1.7 is D816. Unlike β-scorpion toxin trapping sodium channel in an open state, activity of JZTX-34 requires the sodium channel to be in a resting state. JZTX-34 exhibits an obvious analgesic effect in a rodent pain model. Especially, it shows a longer duration and is more effective than morphine in hot pain models. In a formalin-induced pain model, JZTX-34 at dose of 2 mg/kg is equipotent with morphine (5 mg/kg) in the first phase and several-fold more effective than morphine in second phase. Taken together, our data indicate that JZTX-34 releases pain by selectively binding to the domain II voltage sensor of Nav1.7 in a closed configuration.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2018) studied Pain. Jingzhaotoxin-34 (JZTX-34) vs. Morphine (5 mg/kg) was evaluated on Analgesic effect in rodent pain models. JZTX-34 at 2 mg/kg exhibited analgesic effects in rodent pain models, proving equipotent to morphine (5 mg/kg) in the first phase of formalin-induced pain and more effective in the second phase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: